share_log

HC Wainwright & Co. Maintains Buy on Puma Biotechnology, Lowers Price Target to $7

HC Wainwright & Co. Maintains Buy on Puma Biotechnology, Lowers Price Target to $7

HC Wainwright & Co.维持对Puma Biotechnology的买入,将目标股价下调至7美元
Moomoo 24/7 ·  03/01 14:53

HC Wainwright & Co. analyst Edward White maintains Puma Biotechnology (NASDAQ:PBYI) with a Buy and lowers the price target from $8 to $7.

HC Wainwright & Co. 分析师爱德华·怀特维持彪马生物技术(纳斯达克股票代码:PBYI)的买入并将目标股价从8美元下调至7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发